Indian pharma players hope to penetrate China

The Indian pharmaceutical industry is eagerly looking forward to new avenues in the wake of the US-China trade war. Though Chinese regulations are quite complex, the industry is preparing to replace US exports, considering the latent potential in the market.  

Raghuveer Kini, Executive Director, Pharmaceuticals Export Promotion Council of India (Pharmexcil), commented, “Valued at over $19 billion, India’s pharmaceuticals exports are growing at a healthy rate of 11 per cent over last year. And we are expecting the growth to be higher this year at about 15 per cent. The latent potential is the Chinese market. If we are able to capitalise on the US-China trade issues it can open a vast opportunity for us to boost our formulations exports.”